Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ghadimi

Showing results (211-220 of 241) with videos related to

Pageof 25
Sort By:
Cancer Research Communications|July 15, 2024
Tumor Vessel Normalization via PFKFB3 Inhibition Alleviates Hypoxia and Increases Tumor Necrosis in Rectal Cancer upon RadiotherapyMarcus Edelmann, Shuang Fan, Tiago De Oliveira, et al.
Endoscopy|January 28, 2021
Endoscopic internal drainage and low negative-pressure endoscopic vacuum therapy for anastomotic leaks after oncologic upper gastrointestinal surgeryCarlo Felix Maria Jung, Rachel Hallit, Annegret Müller-Dornieden, et al.
Molecular Cancer|January 23, 2023
Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolutionJohannes Robert Fleischer, Alexandra Maria Schmitt, Gwendolyn Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2017
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III TrialMarianne Sinn, Marcus Bahra, Torsten Liersch, et al.
Annals of Surgery|February 21, 2025
Ideal Outcome after Left Pancreatectomy in North America, Germany, the Netherlands, and SwedenTessa E Hendriks, Simone Augustinus, Bodil Andersson, et al.
International Journal of Cancer|October 15, 2019
NO<sup>•</sup> /RUNX3/kynurenine metabolic signaling enhances disease aggressiveness in pancreatic cancerLimin Wang, Wei Tang, Shouhui Yang, et al.
Theranostics|March 15, 2019
A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic CancerAndreas W Berger, Daniel Schwerdel, Anke Reinacher-Schick, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2024
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trialsEmmanouil Fokas, Hannah Williams, Markus Diefenhardt, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2010
A putatively functional haplotype in the gene encoding transforming growth factor beta-1 as a potential biomarker for radiosensitivityMarkus A Schirmer, Jürgen Brockmöller, Margret Rave-Fränk, et al.
Cell Death and Differentiation|June 5, 2021
RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel diseaseRobyn Laura Kosinsky, Maria Zerche, Ana Patricia Kutschat, et al.
Pageof 25

Showing results (211-220 of 241) with videos related to

Sort By:
Pageof 25
Cancer Research Communications|July 15, 2024
Tumor Vessel Normalization via PFKFB3 Inhibition Alleviates Hypoxia and Increases Tumor Necrosis in Rectal Cancer upon RadiotherapyMarcus Edelmann, Shuang Fan, Tiago De Oliveira, et al.
Endoscopy|January 28, 2021
Endoscopic internal drainage and low negative-pressure endoscopic vacuum therapy for anastomotic leaks after oncologic upper gastrointestinal surgeryCarlo Felix Maria Jung, Rachel Hallit, Annegret Müller-Dornieden, et al.
Molecular Cancer|January 23, 2023
Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolutionJohannes Robert Fleischer, Alexandra Maria Schmitt, Gwendolyn Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2017
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III TrialMarianne Sinn, Marcus Bahra, Torsten Liersch, et al.
Annals of Surgery|February 21, 2025
Ideal Outcome after Left Pancreatectomy in North America, Germany, the Netherlands, and SwedenTessa E Hendriks, Simone Augustinus, Bodil Andersson, et al.
International Journal of Cancer|October 15, 2019
NO<sup>•</sup> /RUNX3/kynurenine metabolic signaling enhances disease aggressiveness in pancreatic cancerLimin Wang, Wei Tang, Shouhui Yang, et al.
Theranostics|March 15, 2019
A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic CancerAndreas W Berger, Daniel Schwerdel, Anke Reinacher-Schick, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2024
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trialsEmmanouil Fokas, Hannah Williams, Markus Diefenhardt, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2010
A putatively functional haplotype in the gene encoding transforming growth factor beta-1 as a potential biomarker for radiosensitivityMarkus A Schirmer, Jürgen Brockmöller, Margret Rave-Fränk, et al.
Cell Death and Differentiation|June 5, 2021
RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel diseaseRobyn Laura Kosinsky, Maria Zerche, Ana Patricia Kutschat, et al.
Pageof 25